BIOMAT Database Logo BIOMAT Database Logo

Mineralocorticoid therapy in congenital adrenal hyperplasia. 1978

R McVie, and P Saenger

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D003900 Desoxycorticosterone A steroid metabolite that is the 11-deoxy derivative of CORTICOSTERONE and the 21-hydroxy derivative of PROGESTERONE 21-Hydroxyprogesterone,Cortexone,Deoxycorticosterone,Desoxycortone,11-Decorticosterone,21-Hydroxy-4-pregnene-3,20-dione,11 Decorticosterone,21 Hydroxy 4 pregnene 3,20 dione,21 Hydroxyprogesterone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000308 Adrenocortical Hyperfunction Excess production of ADRENAL CORTEX HORMONES such as ALDOSTERONE; HYDROCORTISONE; DEHYDROEPIANDROSTERONE; and/or ANDROSTENEDIONE. Hyperadrenal syndromes include CUSHING SYNDROME; HYPERALDOSTERONISM; and VIRILISM. Hyperadrenocorticism,Hypercorticism,Adrenal Gland Hyperfunction,Hyperadrenalism,Hyperfunction, Adrenal Gland,Hyperfunction, Adrenocortical

Related Publications

R McVie, and P Saenger
Mineralocorticoid replacement therapy in salt-wasting congenital adrenal hyperplasia.
August 2023, Clinical endocrinology,
R McVie, and P Saenger
Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.
May 1979, Archives of disease in childhood,
R McVie, and P Saenger
Plasma renin activity and mineralocorticoid replacement therapy in congenital adrenal hyperplasia.
January 1979, Acta paediatrica Academiae Scientiarum Hungaricae,
R McVie, and P Saenger
Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia.
January 2010, International journal of pediatric endocrinology,
R McVie, and P Saenger
Hypertension in congenital adrenal hyperplasia and apparent mineralocorticoid excess.
September 2002, Annals of the New York Academy of Sciences,
R McVie, and P Saenger
Reinstitution of mineralocorticoid therapy in congenital adrenal hyperplasia. Effects on control and growth.
March 1981, Acta paediatrica Scandinavica,
R McVie, and P Saenger
Keeping the pressure on mineralocorticoid replacement in congenital adrenal hyperplasia.
April 2015, Clinical endocrinology,
R McVie, and P Saenger
A Rationale for Mineralocorticoid Supplementation in Classic Congenital Adrenal Hyperplasia.
April 2015, Hormone research in paediatrics,
R McVie, and P Saenger
Selective effect of mineralocorticoid replacement therapy on renal acid excretion in congenital adrenal hyperplasia.
January 1990, Acta paediatrica Scandinavica,
R McVie, and P Saenger
Steroid disorders in children: congenital adrenal hyperplasia and apparent mineralocorticoid excess.
October 1999, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!